{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:20:13Z","timestamp":1760955613509},"reference-count":57,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.3892\/mmr.2016.5298","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T08:43:11Z","timestamp":1463560991000},"page":"661-670","source":"Crossref","is-referenced-by-count":8,"title":["Deciphering the genetic and modular connections between coronary heart disease, idiopathic pulmonary arterial hypertension and pulmonary heart disease"],"prefix":"10.3892","volume":"14","author":[{"given":"YE","family":"YUAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YINGYING","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIAOXU","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YANAN","family":"YU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BING","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PENGQIAN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HAIXIA","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YIJUN","family":"ZHAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHUNTI","family":"SHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHONG","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,5,18]]},"reference":[{"key":"key20180108030527_b1-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1055\/s-0033-1355439","article-title":"Idiopathic pulmonary arterial hypertension","volume":"34","author":"Souza","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"key":"key20180108030527_b2-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3724\/SP.J.1263.2012.02131","article-title":"Novel therapy for idiopathic pulmonary arterial hypertension: Can hepatocyte growth factor be beneficial?","volume":"9","author":"Guo","year":"2012","journal-title":"J Geriatr Cardiol"},{"key":"key20180108030527_b3-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"e0139408","DOI":"10.1371\/journal.pone.0139408","article-title":"Correction: The relationship of metabolic syndrome with stress, coronary heart disease and pulmonary function - An occupational cohort-based study","volume":"10","author":"Janczura","year":"2015","journal-title":"PLoS One"},{"key":"key20180108030527_b4-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0140-6736(03)13167-4","article-title":"Primary pulmonary hypertension","volume":"361","author":"Runo","year":"2003","journal-title":"Lancet"},{"key":"key20180108030527_b5-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1136\/hrt.2010.219675","article-title":"Genetic determinants of coronary heart disease: new discoveries and insights from genome-wide association studies","volume":"97","author":"Patel","year":"2011","journal-title":"Heart"},{"key":"key20180108030527_b6-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"541","DOI":"10.5603\/ARM.27541","article-title":"Pulmonary heart disease \u2013 cardiologist's point of view","volume":"80","author":"Lewczuk","year":"2012","journal-title":"Pneumonol Alergol Pol"},{"key":"key20180108030527_b7-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0002-9149(98)00296-3","article-title":"Role of vasoactive mediators in primary and secondary pulmonary hypertension","volume":"82","author":"Mikhail","year":"1998","journal-title":"Am J Cardiol"},{"key":"key20180108030527_b8-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1161\/CIRCULATIONAHA.106.685206","article-title":"Pulmonary diseases and the heart","volume":"116","author":"Han","year":"2007","journal-title":"Circulation"},{"key":"key20180108030527_b9-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1161\/CIR.0b013e318277d6a0","article-title":"2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: A report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines, and the American College of Physicians American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons","volume":"126","author":"Fihn","year":"2012","journal-title":"Circulation"},{"key":"key20180108030527_b10-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.pharmthera.2013.01.016","article-title":"Structure and dynamics of molecular networks: A novel paradigm of drug discovery: A comprehensive review","volume":"138","author":"Csermely","year":"2013","journal-title":"Pharmacol Ther"},{"key":"key20180108030527_b11-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCGENETICS.111.000027","article-title":"Identification of a glutamic acid repeat polymerphism of ALMS1 as a novel genetic risk marker for early-onset myocardial infarction by genome-wide linkage analysis","volume":"6","author":"Ichihara","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"key20180108030527_b12-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.atherosclerosis.2007.12.027","article-title":"Prospective association of vascular endothelial growth factor-A (VEGF-A) with coronary heart disease mortality in southeastern New England","volume":"200","author":"Eaton","year":"2008","journal-title":"Atherosclerosis"},{"key":"key20180108030527_b13-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/nar\/30.1.52","article-title":"Online mendelian inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders","volume":"30","author":"Hamosh","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"key20180108030527_b14-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1289\/ehp.6028","article-title":"The Comparative Toxicogenomics Database (CTD)","volume":"111","author":"Mattingly","year":"2003","journal-title":"Environ Health Perspect"},{"key":"key20180108030527_b15-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1136\/hrt.2004.038364","article-title":"Coronary artery pathology","volume":"93","author":"van der Wal","year":"2007","journal-title":"Heart"},{"key":"key20180108030527_b16-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2217\/14622416.8.12.1723","article-title":"Endothelial nitric oxide synthase gene: Prospects for treatment of heart disease","volume":"8","author":"Cooke","year":"2007","journal-title":"Pharmacogenomics"},{"key":"key20180108030527_b17-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1373\/49.3.389","article-title":"Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease","volume":"49","author":"Colombo","year":"2003","journal-title":"Clin Chem"},{"key":"key20180108030527_b18-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"L512","DOI":"10.1152\/ajplung.00289.2011","article-title":"Abnormal platelet aggregation in idiopathic pulmonary arterial hypertension: Role of nitric oxide","volume":"302","author":"Aytekin","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"key20180108030527_b19-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH715>3.0.CO;2-Q","article-title":"Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension","volume":"192","author":"Orte","year":"2000","journal-title":"J Pathol"},{"key":"key20180108030527_b20-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/01.CIR.91.2.270","article-title":"A DNA Variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the caerphilly heart study","volume":"91","author":"Mattu","year":"1995","journal-title":"Circulation"},{"key":"key20180108030527_b21-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/hc3401.093155","article-title":"Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expression in monocrotaline-induced pulmonary arterial hypertension in rats","volume":"104","author":"Kanno","year":"2001","journal-title":"Circulation"},{"key":"key20180108030527_b22-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.106.636662","article-title":"Chronic kidney disease: Tipping the scale to the benefit of angiotensin-converting enzyme inhibitors in patients with coronary artery disease","volume":"114","author":"McCullough","year":"2006","journal-title":"Circulation"},{"key":"key20180108030527_b23-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/01.CIR.98.17.1735","article-title":"Differential regulation of cardiac angiotensin converting enzyme binding sites and AT1 receptor density in the failing human heart","volume":"98","author":"Zisman","year":"1998","journal-title":"Circulation"},{"key":"key20180108030527_b24-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/ATVBAHA.109.201673","article-title":"Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor\u2212\/\u2212mice","volume":"30","author":"Bietrix","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20180108030527_b25-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2016.03.016","article-title":"Total cholesterol as a risk factor for coronary heart disease and stroke in women compared with men: A systematic review and meta-analysis","volume":"248","author":"Peters","year":"2016","journal-title":"Atherosclerosis"},{"key":"key20180108030527_b26-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.pharmthera.2006.02.003","article-title":"Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease","volume":"111","author":"Chapman","year":"2006","journal-title":"Pharmacol Ther"},{"key":"key20180108030527_b27-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.atherosclerosis.2013.09.023","article-title":"Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: The Hisayama Study","volume":"231","author":"Ninomiya","year":"2013","journal-title":"Atherosclerosis"},{"key":"key20180108030527_b28-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"e12798","DOI":"10.1371\/journal.pone.0012798","article-title":"Regulation of thromboxane receptor signaling at multiple levels by oxidative stress-induced stabilization, relocation and enhanced responsiveness","volume":"5","author":"Ball","year":"2010","journal-title":"PLoS One"},{"key":"key20180108030527_b29-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/2045-8932.97605","article-title":"Furegrelate, a thromboxane synthase inhibitor, blunts the development of pulmonary arterial hypertension in neonatal piglets","volume":"2","author":"Hirenallur-S","year":"2012","journal-title":"Pulm Circ"},{"key":"key20180108030527_b30-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/01.CIR.0000035277.48823.01","article-title":"Acute pulmonary embolism: Don't ignore the platelet","volume":"106","author":"Sobieszczyk","year":"2002","journal-title":"Circulation"},{"key":"key20180108030527_b31-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1161\/01.CIR.0000097829.89204.0C","article-title":"Acute pulmonary embolism: Part I epidemiology, pathophysiology, and diagnosis","volume":"108","author":"Goldhaber","year":"2003","journal-title":"Circulation"},{"key":"key20180108030527_b32-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12026-014-8492-5","article-title":"Leukotrienes in pulmonary arterial hypertension","volume":"58","author":"Tian","year":"2014","journal-title":"Immunol Res"},{"key":"key20180108030527_b33-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5551\/jat.20123","article-title":"Expression analysis of leukotriene-inflammatory gene interaction network in patients with coronary artery disease","volume":"21","author":"Nair","year":"2014","journal-title":"J Atheroscler Thromb"},{"key":"key20180108030527_b34-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/000331978803900503","article-title":"Oxygen free radicals and heart failure","volume":"39","author":"Prasad","year":"1988","journal-title":"Angiology"},{"key":"key20180108030527_b35-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/bies.20511","article-title":"Coupled positive and negative feedback circuits form an essential building block of cellular signaling pathways","volume":"29","author":"Kim","year":"2007","journal-title":"Bioessays"},{"key":"key20180108030527_b36-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/ATVBAHA.110.204719","article-title":"Epicardial adipokines in obesity and coronary artery disease induce atherogenic changes in monocytes and endothelial cells","volume":"30","author":"Karastergiou","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20180108030527_b37-mmr-14-01-0661","first-page":"e40","article-title":"Atorvastatin improves endothelial progenitor cell function and reduces pulmonary hypertension in patients with chronic pulmonary heart disease","volume":"18","author":"Liu","year":"2013","journal-title":"Exp Clin Cardiol"},{"key":"key20180108030527_b38-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2119\/molmed.2013.00165","article-title":"Molecular mechanisms of pulmonary arterial remodeling","volume":"20","author":"Crosswhite","year":"2014","journal-title":"Mol Med"},{"key":"key20180108030527_b39-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1183\/09031936.00105807","article-title":"Enhancement of pulmonary vascular remodelling and inflammatory genes with VIP gene deletion","volume":"31","author":"Hamidi","year":"2008","journal-title":"Eur Respir J"},{"key":"key20180108030527_b40-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1161\/01.CIR.0000079055.99427.3F","article-title":"Inflammatory markers in coronary heart disease: Coronary vascular versus myocardial origin?","volume":"108","author":"Heusch","year":"2003","journal-title":"Circulation"},{"key":"key20180108030527_b41-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1161\/01.CIR.102.17.2111","article-title":"Evidence for oxidative activation of c-Myc-Dependent nuclear signaling in human coronary smooth muscle cells and in early lesions of watanabe heritable hyperlipidemic rabbits: Protective effects of vitamin E","volume":"102","author":"de Nigris","year":"2000","journal-title":"Circulation"},{"key":"key20180108030527_b42-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.acvd.2009.12.001","article-title":"Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France","volume":"103","author":"Fraisse","year":"2010","journal-title":"Arch Cardiovasc Dis"},{"key":"key20180108030527_b43-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/01.CIR.42.4.625","article-title":"Prediction of coronary heart disease based on clinical suspicion, age, total cholesterol, and triglyceride","volume":"42","author":"Page","year":"1970","journal-title":"Circulation"},{"key":"key20180108030527_b44-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0735-1097(99)00525-2","article-title":"The evolving role of statins in the management of atherosclerosis","volume":"35","author":"Vaughan","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"key20180108030527_b45-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.CIR.101.2.207","article-title":"Current perspectives on statins","volume":"101","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"key20180108030527_b46-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"key20180108030527_b47-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.0000151788.08740.5C","article-title":"Cardiac rehabilitation and secondary prevention of coronary heart disease","volume":"111","author":"Yusuf","year":"2005","journal-title":"Circulation"},{"key":"key20180108030527_b48-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(01)00157-7","article-title":"Pulmonary vascular remodeling: A target for therapeutic intervention in pulmonary hypertension","volume":"92","author":"Jeffery","year":"2001","journal-title":"Pharmacol Ther"},{"key":"key20180108030527_b49-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.CIR.0000102381.57477.50","article-title":"Endothelial dysfunction in pulmonary hypertension","volume":"109","author":"Budhiraja","year":"2004","journal-title":"Circulation"},{"key":"key20180108030527_b50-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.0000094397.19932.78","article-title":"Endothelin receptor blockers in cardiovascular disease","volume":"108","author":"Rich","year":"2003","journal-title":"Circulation"},{"key":"key20180108030527_b51-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.CIR.95.1.221","article-title":"Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis","volume":"95","author":"Minamino","year":"1997","journal-title":"Circulation"},{"key":"key20180108030527_b52-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0735-1097(10)80214-1","article-title":"Increased plasma endothelin-1 in the early hours of acute myocardial infarction","volume":"18","author":"Stewart","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"key20180108030527_b53-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/CIRCULATIONAHA.110.967406","article-title":"Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis","volume":"122","author":"Reriani","year":"2010","journal-title":"Circulation"},{"key":"key20180108030527_b54-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fimmu.2014.00003","article-title":"TWEAK\/Fn14 Axis: A promising target for the treatment of cardiovascular diseases","volume":"5","author":"Blanco-Colio","year":"2014","journal-title":"Front Immunol"},{"key":"key20180108030527_b55-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"L740","DOI":"10.1152\/ajplung.00284.2002","article-title":"Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells","volume":"285","author":"Zhang","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"key20180108030527_b56-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/CIRCULATIONAHA.105.540542","article-title":"Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension","volume":"112","author":"Merklinger","year":"2005","journal-title":"Circulation"},{"key":"key20180108030527_b57-mmr-14-01-0661","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.jacc.2005.01.069","article-title":"Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary heart disease: The IACT-study","volume":"46","author":"Strauer","year":"2005","journal-title":"J Am Coll Cardiol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2016.5298\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T01:08:48Z","timestamp":1656119328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2016.5298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,18]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,5,18]]},"published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.3892\/mmr.2016.5298"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2016.5298","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,18]]}}}